Package 42571-313-97

{"route": ["INTRAVENOUS"], "spl_id": "874186a5-c314-9d21-e053-2995a90ae376", "openfda": {"upc": ["0342571313753", "0342571313869"], "unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["9c89764e-ff07-4077-a40f-91eb1c179af2"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (42571-313-75)  / 2 mL in 1 VIAL", "package_ndc": "42571-313-75", "marketing_start_date": "20190304"}, {"sample": false, "description": "1 VIAL in 1 CARTON (42571-313-86)  / 4 mL in 1 VIAL", "package_ndc": "42571-313-86", "marketing_start_date": "20190304"}, {"sample": false, "description": "25 VIAL in 1 CARTON (42571-313-87)  / 2 mL in 1 VIAL", "package_ndc": "42571-313-87", "marketing_start_date": "20190424"}, {"sample": false, "description": "5 VIAL in 1 CARTON (42571-313-96)  / 4 mL in 1 VIAL", "package_ndc": "42571-313-96", "marketing_start_date": "20190424"}, {"sample": false, "description": "5 VIAL in 1 CARTON (42571-313-97)  / 2 mL in 1 VIAL", "package_ndc": "42571-313-97", "marketing_start_date": "20190424"}], "brand_name": "Verapamil Hydrochloride", "product_id": "42571-313_874186a5-c314-9d21-e053-2995a90ae376", "dosage_form": "INJECTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "42571-313", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA211370", "marketing_category": "ANDA", "marketing_start_date": "20190304", "listing_expiration_date": "20261231"}